Dayton Clinical Oncology Program — Dayton, Ohio

Dayton Clinical Oncology Program is a clinical research site located in Dayton, Ohio, United States 45429.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Dayton Clinical Oncology Program has participated in 11 clinical trials.

Therapeutic areas: Diffuse Large-Cell Lymphoma, Breast Neoplasms, Osteoporosis.

Sponsors: CTI BioPharma, Novartis Pharmaceuticals, University of Rochester NCORP Research Base.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dayton Clinical Oncology Program?

Dayton Clinical Oncology Program has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dayton Clinical Oncology Program conducted?

Dayton Clinical Oncology Program has 11 clinical trials on record. Their work covers Diffuse Large-Cell Lymphoma, Breast Neoplasms, Osteoporosis.

Is Dayton Clinical Oncology Program accredited by Crixeo Health?

Yes — Dayton Clinical Oncology Program holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Dayton Clinical Oncology Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.